Landmark TRIC Valve Implantation at Dana Shivam Heart & Superspeciality Hospital, Jaipur by Dr Sunil Garssa

Jaipur (Rajasthan) [India], June 7:  In a significant milestone for interventional cardiology, a 75-year-old female patient suffering from severe tricuspid valve regurgitation and right heart failure was successfully treated with a percutaneous TRIC valve implantation at Dana Shivam Heart & Superspeciality Hospital, Jaipur. The procedure was led by Dr. Sunil Kumar Garssa (MD, DM, FACC, FSCAI), Senior Consultant Cardiologist and Director of the Cardiac Cath Lab.

Case Overview: Debilitating Symptoms and High Risk

The patient presented with right heart failure, manifesting as pedal edema, ascites, and pleural effusion. Her condition was so severe that she was unable to walk to the bathroom independently. Initial management was conservative, involving medication and pleural fluid aspiration, which provided only limited symptomatic relief.

Diagnostic Findings: Severe Valve Regurgitation with Preserved LV Function

Echocardiography revealed:

  • Normal left ventricular (LV) function
  • Severe tricuspid valve regurgitation
  • Near-normal right ventricular (RV) pressures
  • Funnel-shaped inferior and superior vena cava (IVC and SVC) — a sign of chronic venous congestion

Minimally Invasive Procedure: Expertise-Driven and Incision-Free

The TRIC valve implantation was performed via the right femoral vein using a completely percutaneous approach — no incision or stitches were required. This advanced intervention demands a high level of expertise, especially given the fragile condition of the patient and the complexity of the tricuspid valve anatomy.

Dr. Sunil Kumar Garssa, who has over 19 years of cardiology experience, emphasized the technical challenges of the case. “These are very high-risk, symptomatic patients. A detailed understanding of anatomy and solid procedural experience is essential,” he stated.

Successful Outcome: Quick Recovery and Discharge

The procedure was uneventful, and the patient made a swift recovery:

  • Transferred to general ward the next day
  • Discharged shortly thereafter
  • Now ambulatory and able to walk independently

TRIC

About Dr. Sunil Kumar Garssa

Dr. Garssa is renowned for his proficiency in:

  • Radial angiography and angioplasty
  • Percutaneous interventions for congenital heart disease (e.g., PDA and ASD device closures)
  • Complex structural heart disease interventions

He currently serves as Senior Consultant in Cardiology and Director of Cardiac Cath Lab at Dana Shivam Heart & Superspeciality Hospital.

A Model of Innovation and Expertise in Cardiology

This successful TRIC valve implantation demonstrates the hospital’s commitment to cutting-edge cardiac care and underscores Dr. Garssa’s leadership in interventional cardiology. The case represents a beacon of hope for elderly patients with inoperable tricuspid valve disease and severe symptoms.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Brand Ambassador EBITDA eps Finance Financial Results H1 FY27 Jaipur pat Preity Zinta shyam-dhani-industries shyam-kitchen-spices shyamdhani Total Income

Shyam Dhani Industries Limited Reports H1 FY27 Financial Performance

H1 FY27 Total Income of ₹8,411.29 Lakh, up 31.79% YoY, EBITDA of ₹1,004.58 Lakh, up 15.41% YoY, and PAT of ₹548.66 Lakh, up 30.62% YoY Jaipur (Rajasthan) [India], November 16: Shyam Dhani Industries Limited (NSE: SHYAMDHANI), a Jaipur-based FMCG company and one of Rajasthan’s recognised spice brands, engaged in the manufacturing and marketing of over […]

Read More
apollo-clinic apollo-diagnostics apollo-family-health-card diagnostics Gurugram Health national-reference-laboratory preventive healthcare saina-nehwal sangita-reddy sector-52

Apollo Health strengthens its expansion in North India with New Clinic and National Reference Laboratory in Gurugram

Apollo Clinic and Apollo Diagnostic’ National Reference Laboratory, have joined forces together to establish a comprehensive healthcare facility in sector 52, Gurugram, strengthening its healthcare expansion in Northern India. Inaugurated in the presence of Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, and Ms. Saina Nehwal, first Indian badminton player to have won an […]

Read More
Aayush Wellness Energy fulvic acid Health heavy-metal-testing himalayan-shilajit-drops nutraceuticals shilajit Singapore southeast-asia stamina vitality wellness

Aayush Wellness Launches Himalayan Shilajit Drops as Global Shilajit Market is Projected to Reach USD 436.72 Million by 2034, Growing at 8.67% CAGR

The launch strengthens Aayush Wellness’s nutraceutical portfolio, leveraging its Singapore presence to tap into growing global demand and explore expansion opportunities across Southeast Asia and international markets. Mumbai, November 13, 2026: Aayush Wellness Limited (BSE: 539528), an integrated healthcare and wellness company, has announced the launch of its Aayush Wellness Himalayan Shilajit Drops, marking its […]

Read More